X G Yu Selected Research

Persistent Infection

9/2001

Vpr is preferentially targeted by CTL during HIV-1 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

X G Yu Research Topics

Disease

4	Infections 01/2005 - 09/2001
1	Postoperative Hemorrhage 02/2020
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 05/2017
1	Disease Progression 01/2017
1	Viremia 01/2017
1	Persistent Infection 09/2001

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2005 - 09/2001
2	AIDS VaccinesIBA 09/2002 - 09/2001
2	EpitopesIBA 09/2002 - 09/2001
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	HLA-B57 antigenIBA 01/2017
1	Protein Subunits (Protein Subunit)IBA 02/2003
1	EnzymesIBA 02/2003
1	Interferon-gamma (Interferon, gamma)IBA 02/2003
1	Peptides (Polypeptides)IBA 02/2003
1	difluprednate FDA Link 02/2003

Therapy/Procedure

1	Length of Stay 02/2020